A comprehensive view of Drug Delivery / Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Vanda Pharmaceuticals' attempts to uphold patents for circadian rhythm drug Hetlioz denied by the US Supreme Court; the decision follows an earlier legal loss against generic drug manufacturers Teva and Apotex & an FDA rejection of Hetlioz usage expansion
Published: April 23, 2024 by FiercePharma
Par Pharmaceutical expands recall to include seven lots of Treprostinil Injection 20mg/20mL due to the possibility of silicone particulates in the product; affected product is distributed in 20mL multidose vials as sterile solutions in water for injection
Published: April 23, 2024 by PR Newswire
Sanofi's rilzabrutinib meets primary endpoint in Phase 3 LUNA 3 study for immune thrombocytopenia; potential for clinically beneficial treatment of several immune diseases underscored, with regulatory submissions in the US and EU expected by year-end
Published: April 23, 2024 by Sanofi SA
Patent Issued for Drug cassette, autoinjector, and autoinjector system (USPTO 11944798)
Published: April 23, 2024 by Biotech Business Daily
Eli Lilly to acquire FDA-approved manufacturing facility from Nexus Pharmaceuticals to expand its injectable product manufacturing and meet increased demands; production at the Pleasant Prairie, Wisconsin, facility projected to start by end of 2025
Published: April 22, 2024 by Eli Lilly & Co.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count